Leverage our Patented Technology
Patent Licensing of the M5 iE micro molding technology and process available for US companies.
Patent Licensing of the M5 iE micro molding technology and
process available to United States companies only.
Molding multiple parts from one pellet's worth of plastic is a challenge that growing numbers of molders want to tackle. It is driving development of new technology in injection machines, tooling, parts handling, and inspection.
Business Case for M5 Micro MoldingTechnology:
There currently are no standard off-the-shelf injection molding machines available on the market that are capable of injection shot sizes less than .05-.015 grams, and at these shot weights, repeatability and residence times are often an issue.
There is a need for an injection molding machine that can mold micro sized parts (.0005-.1g) with minimal to zero runner waste.
Run your moldable materials efficiently.
-
API Resins
-
Bioresorbable
-
Fluoropolymers
-
Long Term Implantables
-
All Thermoplastic Resins
-
Liquid Silicone Rubber (LSR)
-
MIM (Cobalt Chrome • SST • Titanium) & others
M5 has development such a technology, that has been proven to work and is being used in commercial applications.
Click here to contact us • Heidenhain article about M5
Material cost savings
Technology
M5 iE (intelligent energy)
High Performance Desktop Micro Molding Platform
• Direct Cavity Injection
• Fully Automatable
• Near Zero Material Waste
• Fast Rapid prototyping iterations
• Machine Footprint 9” x 22” x 22”
• Mold Head 9” x 4” x 4”
• Mold head can run remote from machine base
DEVELOPMENT TIMELINE
Late 2015
First test of micro molding head and open platform.
2016
Rev I - ENCLOSED PLATFORM - Cooling External
Rev II - Auto Mold
Rev III - Actuating Arms - External
Rev IV - Cooling System - Internal
2017
Rev V - All Internal
Rev A - Production Platform Ready for launch!!
2018
Build multiple units for internal micro molding contracts
Running multiple projects internal @ M5
2019
Running multiple projects internal @ M5
2020
Patent issued!
2023
Ready for Patent licensing.
The Global Orthopedic Biomaterials Market size is expected to reach $20.4 billion by 2025, rising at a market growth of 10.2% CAGR during the forecast period.
The global implantable biomaterials market size is expected to
grow from $101.91 billion in 2021 to $113.64 billion in 2022 at a compound annual growth rate (CAGR) of 11.5%. The global implantable biomaterial market size is expected to grow to $180.87 billion in 2026 at a CAGR of 12.3%.
The global PEEK is projected to be worth USD 1,225.7 Million by 2027 growing at a CAGR OF 6.8%
See report here.
